Navigation Links
Delcath Strengthens Research and Development Team with Key Appointments
Date:10/20/2010

NEW YORK, Oct. 20 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH) today announced the appointment of William M. Appling as Senior Vice President of Medical Device Research and Development and Queensbury Facility Operations, and Daniel S. Johnston, PhD, to the position of Vice President of Pharmaceutical Research and Development. Mr. Appling and Dr. Johnston will be based in the Company's Queensbury, New York facility and report to Krishna Kandarpa, MD, PhD, Executive Vice President of Research and Development and Delcath's Chief Medical Officer.

"These key appointments now complete our Research & Development senior leadership team, and add significant expertise in medical device and pharmaceutical development to our organization as a whole," said Eamonn P. Hobbs, President and CEO. "Bill brings deep technical and organizational skills to our R&D and Operations teams, and Dan adds strong knowledge of oncology drug development that will be important as we pursue additional indications for our Chemosaturation System. We are pleased to welcome Bill and Dan to Delcath, and look forward to their contributions to successful commercialization of Chemosaturation."

Prior to joining Delcath, Mr. Appling was employed by AngioDynamics, Inc. where he held various management positions of increasing responsibility. Most recently, he served as Senior Vice President of Research and Development responsible for advanced research, process engineering, and managing an intellectual property portfolio of 285 issued patents and patent applications. Mr. Appling has been included as a named inventor on over 31 issued patents, and 30 pending patent applications. Prior to that, he was Manager of Product Development at E-Z-EM, Inc. Previously, Mr. Appling held product development positions at NAMIC, Inc., American Edwards Labs and Sheridan Catheter Corp.

Dr. Johnston
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Signs Agreement With Synerx and Mylans Bioniche Teoranta for Melphalan Supply
2. Delcath to Present at the William Blair Emerging Growth Stock Conference
3. Delcath to Present at the JMP Securities Healthcare Conference
4. Delcath Systems Announces Completion of Common Stock Offering
5. Delcath to Present at the 30th Annual Canaccord Global Growth Conference
6. Delcath to Present at the 2010 Wedbush Securities Life Sciences Best Ideas Management Access Conference
7. Delcath Systems Announces Second Quarter Progress Report Conference Call
8. Delcath Reconfirms Presentation During American Society of Clinical Oncology 2010 Annual Meeting in Chicago
9. Delcaths Eamonn Hobbs to Ring NASDAQ Opening Bell
10. Delcath Systems Provides Update on Corporate Developments
11. Delcath Signs First Partner Agreement in Asia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health ... several new IT value-added reseller (VAR) national contracts that ... goods and services at lower costs. These include manufacturer ... such as initiative assistance and ongoing IT consulting support. ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ... (OFT) approval condition to the announced tender offer for all of ... As a result of the waiver, the transaction is no longer ... offer on January 24, 2014 following the currently scheduled expiration time, ...
(Date:1/15/2014)... Ky. , Jan. 15, 2014  Manufacturers, suppliers ... must be able to protect their most important ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of ... it steadfastly remains one of the most litigious ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2
... Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), ... human disease, announced today that Dr. Roy Fleischmann from ... presenting data from Lexicon,s LX2931 Phase 2 ... American College of Rheumatology on Wednesday, November 9, 2011 ...
... Nov. 8, 2011 Mesa Laboratories, Inc. (NASDAQ: ... declared a regular quarterly dividend of $.13 per share of ... dividend will be payable December 15, 2011, to shareholders of ... in 1984 Mesa Labs has maintained strong cash positions and ...
Cached Medicine Technology:LX2931 Phase 2 Data to be Presented at the American College of Rheumatology Conference 2LX2931 Phase 2 Data to be Presented at the American College of Rheumatology Conference 3
(Date:7/11/2014)... Steven Reinberg HealthDay Reporter ... depression may increase the risk for stroke, a new study ... the risk of a stroke or a transient ischemic ... apparently raised stroke or TIA risk by 59 percent. And ... a mini-stroke caused by a temporary blockage of blood flow ...
(Date:7/11/2014)... the distinguished wedding dress manufacturer and retailer, has recently ... . To top it all off, all these high ... to 65% off. Clients who place orders on the ... Fadhits.com is devoted to designing and selling beautiful wedding ... All its items come with very fast delivery. More ...
(Date:7/11/2014)... San Francisco shows that an "expressive therapy" group ... living with HIV disclose their health status and ... and quality of their relationships., "Medication alone is ... L. Machtinger, MD, director of the Women,s HIV ... patients are on effective antiretroviral therapy but far ...
(Date:7/11/2014)... 11, 2014 Bedros Keuilian is known in ... he’s earned by founding the fast-selling fitness franchise in the ... businesses. He works with successful boot camp owners on a ... the traits of the most successful boot camp owners , ... qualities. , “I’ve worked with and coached some of the ...
(Date:7/11/2014)... When the mercury rises, heat can strain the limits of ... on a heavier load in hot weather to keep body ... Harvard Men's Health Watch . , For otherwise fit, ... their limits and drinking enough fluids. But what about men ... to the heat," says Dr. Joanne Foody, Director of cardiovascular ...
Breaking Medicine News(10 mins):Health News:Stress, Depression May Boost Stroke Risk, Study Finds 2Health News:Stress, Depression May Boost Stroke Risk, Study Finds 3Health News:Elegant Lace Holiday Dresses Released by Fadhits.com 2Health News:'Expressive therapy" intervention assists women living with HIV 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 3Health News:Take Common Sense Steps to Stay Safe This Summer, from the July 2014 Harvard Men's Health Watch 2Health News:Take Common Sense Steps to Stay Safe This Summer, from the July 2014 Harvard Men's Health Watch 3
... is a form of arthritis where one or more ... in these type of joint problems is the loss ... that moisturizes the area. This fluid is called synovial ... since 1987, after the therapy was proved beneficial in// ...
... Institute, has succeeded in finding a new biosensor ... a breakthrough technology that will help scientific researchers ... of neurons, nerve tissue and organic neural networks. ... metal oxide semiconductor technology extended with additional process ...
... currently testing the safety of hypothermia as a ... treatment has been shown to be effective for ... effectiveness in treating children with traumatic brain injuries ... excitotoxicity (excessive neurotransmitters released with injury that damage ...
... of Durham in England has reported a discovery, that adds ... ones, for breast feeding of babies. Babies who are breast-fed ... than babies who are bottle-fed in bed. The study included ... while they slept. Researchers found that mothers who breast-fed their ...
... received a patient, a two-month-old baby with white blood! The ... caused due to a deficiency of lipoprotein lipase. This disease ... said that the baby was brought to the hospital with ... boy child, was found to have lipemic blood. Doctors said ...
... study published in the journal, Molecular Psychiatry suggested that scientists ... to sleepwalking. Sleepwalking is a complex disorder and affects around ... of adults. Though the condition is harmless, it may sometimes ... others. Scientists examined a family of genes known as HLA ...
Cached Medicine News:
The Natural-Knee Family is a complete range of interchangeable, anatomically-designed implants with over 14 years of proven clinical results....
Maximum contact. Minimum wear. Outstanding results....
... tricompartmental total knee prosthesis stems from many ... design and manufacturing technologies have been used ... as well as a favorable pressure distribution ... keep wear to a minimum. The inherent ...
...
Medicine Products: